Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | No references |
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Leishmania major | cytochrome p450-like protein | cytochrome P450, family 2, subfamily C, polypeptide 19 | 490 aa | 411 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 0.0643 | 0.0643 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0112 | 0.025 | 0.0864 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0112 | 0.025 | 0.0864 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0442 | 0.178 | 1 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0128 | 0.0322 | 0.0471 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.0516 | 0.1783 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0112 | 0.025 | 0.9696 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0128 | 0.0322 | 0.3075 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 0.0643 | 0.2568 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0273 | 0.0995 | 0.0995 |
Onchocerca volvulus | 0.0112 | 0.025 | 0.9696 | |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.0516 | 0.1783 |
Loa Loa (eye worm) | MBCTL1 | 0.0128 | 0.0322 | 0.0322 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0112 | 0.025 | 0.025 |
Loa Loa (eye worm) | hypothetical protein | 0.2213 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.025 | 0.025 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0128 | 0.0322 | 0.1113 |
Onchocerca volvulus | 0.0114 | 0.0258 | 1 | |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0128 | 0.0322 | 0.0471 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0128 | 0.0322 | 0.0471 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0112 | 0.025 | 0.0864 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.2213 | 1 | 1 |
Brugia malayi | mbt repeat family protein | 0.0112 | 0.025 | 0.2335 |
Schistosoma mansoni | hypothetical protein | 0.0681 | 0.2892 | 1 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0128 | 0.0322 | 0.0471 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0063 | 0.0023 | 0.0023 |
Brugia malayi | follicle stimulating hormone receptor | 0.0273 | 0.0995 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0128 | 0.0322 | 0.0322 |
Echinococcus multilocularis | tumor protein p63 | 0.0398 | 0.1576 | 0.8669 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.0643 | 0.2568 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.0643 | 0.2568 |
Brugia malayi | mbt repeat family protein | 0.0112 | 0.025 | 0.2335 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0197 | 0.0643 | 0.6374 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0442 | 0.178 | 1 |
Toxoplasma gondii | hypothetical protein | 0.2213 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2213 | 1 | 1 |
Echinococcus granulosus | tumor protein p63 | 0.0398 | 0.1576 | 0.8669 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 0.223872114 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 0.891250938 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 5.011872336 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 12.58925412 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Potency (functional) | = 0.1778 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 0.1778 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.